StockWatch
·
Commodity Chemicals
Board Meeting25 May 2026, 12:46 pm

Fischer Medical Ventures Board Meeting on May 29, 2026

AI Summary

Fischer Medical Ventures Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board will also consider recommending a dividend, if any. The trading window for dealing in the company's equity shares remains closed until 48 hours after the declaration of the financial results.

Key Highlights

  • Board meeting scheduled for May 29, 2026, via video conferencing.
  • Audited financial results for Q4 and FY26 to be considered.
  • Dividend recommendation to be discussed.
  • Trading window remains closed until 48 hours post results declaration.